🔎 Trials Near Me

Utama › Demensia › New Jersey

Kajian klinikal Demensia di New Jersey

8 kajian untuk Demensia sedang mencari peserta di lokasi di New Jersey.

Bandar di New Jersey

Teks kajian rasmi (Bahasa Inggeris)

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, West Long Branch
Mengambil pesertaFasa 2
Umur 55 hingga 90 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06887192

Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons

  • Kessler Foundation, East Hanover
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05048966

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  • The Cognitive and Research Center of New Jersey, Springfield
  • Advanced Clinical Institute, West Long Branch
Mengambil pesertaFasa 3
Umur 60 hingga 85 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06976203

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

  • CenExel AMRI, Toms River
Mengambil pesertaFasa 1
Umur 50 hingga 85 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT06297590

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  • Advanced Memory Research Institute of New Jersey, Toms River
Mengambil pesertaFasa 3
Umur 60 hingga 85 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT06976216

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  • The Cognitive and Research Center of New Jersey, Springfield
Mengambil pesertaFasa 3
Umur 55 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT07602582

Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol

  • Nuclear Imaging Institute, Englewood
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
Umur 18 hingga 120 · Semua jantina · Dikemas kini 13 Apr 2026 · NCT07012993

Open-label Extension Study in Participants With Early Alzheimer's Disease

  • GSK Investigational Site, Toms River
Mengambil pesertaFasa 2
Umur 50 hingga 85 · Semua jantina · Dikemas kini 2 Feb 2026 · NCT07105709

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.